Personalized Medicine Biomarkers Market

The personalized medicine biomarkers market consists of biological indicators used to predict disease risk, diagnose conditions, and monitor treatment responses, enabling targeted therapies. The primary customers are pharmaceutical companies, diagnostic firms, and research organizations developing solutions for patients with chronic conditions. Key growth drivers include the rising demand for precision medicine, advancements in genomic and proteomic technologies, and the increasing prevalence of chronic diseases within an aging global population.